X4 Pharmaceuticals, Inc. (XFOR) Financials

XFOR Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 173.3 million 105.7 million
2023-06-30 173.4 million 105.9 million
2023-03-31 173.4 million 105.9 million
2022-12-31 124.4 million 72.7 million

XFOR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -20.8 million 2.4 million
2023-06-30 -21.4 million 2.1 million
2023-03-31 -21.4 million 2.1 million
2022-12-31 -26.5 million 1.6 million

XFOR Net Income

No data available :(

XFOR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 141.7 million - 4.0 million
2023-06-30 141.3 million - 4.3 million
2023-03-31 141.3 million - 4.6 million
2022-12-31 93.4 million - 4.8 million

XFOR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 197.0 million
2023-06-30 168.7 million
2023-03-31 168.7 million
2022-12-31 146.0 million

XFOR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 8000 19.1 million 8.1 million -
2023-06-30 8000 15.6 million 10.2 million -
2023-03-31 8000 15.6 million 7.2 million -
2022-12-31 9000 22.1 million 14.4 million 7.2 million

XFOR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 502000
2023-06-30 - 516000
2023-03-31 - 512000
2022-12-31 - 501000

XFOR

Price: $1.10

52 week price:
0.57
2.58

Earnings Per Share: -0.57 USD

P/E Ratio: -1.35

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 471700

Market Capitalization: 221.7 million

Links: